LIC MF Healthcare Fund Direct G
Summary Info
Fund Name
: LIC Mutual Fund
Scheme Name
: LIC MF Healthcare Fund Direct G
AMC
: LIC Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 08-Feb-2019
Fund Manager
: Karan Doshi
Net Assets (Rs. cr)
: 87.59
LIC MF Healthcare Fund Direct G - Nav Details
Nav Date
: 20-Nov-2025
NAV [Rs.]
: 32.7292
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: 1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.
LIC MF Healthcare Fund Direct G- NAV Chart
LIC MF Healthcare Fund Direct G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -0.18 | -0.31 | 1.2 | 6.85 | 4.41 | 21.93 | 15.64 | 19.3 |
| Category Avg | -0.12 | -0.37 | -0.35 | 4.83 | 4.35 | 23.19 | 18.37 | 15.84 |
| Category Best | 0.69 | 1.01 | 1.94 | 10.09 | 12.57 | 29.04 | 21.63 | 31.35 |
| Category Worst | -0.75 | -1.86 | -2.64 | 0.66 | -1.6 | 19.35 | 14.23 | -3.8 |
LIC MF Healthcare Fund Direct G- Latest Dividends
No Records Found
LIC MF Healthcare Fund Direct G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 500
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
J B Chemicals &9,736
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 10.39 | 53851 | 9.10 |
| Equity | Apollo Hospitals | Healthcare Services | 5.90 | 6723 | 5.16 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 5.35 | 31218 | 4.68 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 5.34 | 13130 | 4.67 |
| Equity | Fortis Health. | Healthcare Services | 4.92 | 42102 | 4.30 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 4.74 | 6158 | 4.14 |
| Equity | Neuland Labs. | Pharmaceuticals & Biotechnology | 4.54 | 2414 | 3.97 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 4.52 | 198385 | 3.96 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.07 | 31301 | 3.56 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.91 | 6212 | 3.42 |
| Equity | OneSource Speci. | Pharmaceuticals & Biotechnology | 3.59 | 16962 | 3.14 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 3.20 | 968 | 2.80 |
| Equity | Navin Fluo.Intl. | Chemicals & Petrochemicals | 3.11 | 4796 | 2.72 |
| Equity | Artemis Medicare | Healthcare Services | 3.08 | 108832 | 2.69 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.94 | 13351 | 2.57 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.66 | 18311 | 2.32 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 2.59 | 11994 | 2.26 |
| Equity | Metropolis Healt | Healthcare Services | 2.57 | 11417 | 2.24 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.33 | 8577 | 2.04 |
| Equity | Dr Agarwal's Hea | Healthcare Services | 2.29 | 39576 | 2.00 |
| Equity | Global Health | Healthcare Services | 2.24 | 14952 | 1.96 |
| Equity | Max Healthcare | Healthcare Services | 2.20 | 16775 | 1.92 |
| Equity | Syngene Intl. | Healthcare Services | 2.10 | 28260 | 1.83 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 2.03 | 12341 | 1.78 |
| Equity | Acutaas Chemical | Pharmaceuticals & Biotechnology | 1.92 | 9711 | 1.67 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 1.86 | 22961 | 1.63 |
| Equity | Vinati Organics | Chemicals & Petrochemicals | 1.65 | 8741 | 1.44 |
| Equity | Linde India | Chemicals & Petrochemicals | 1.07 | 1559 | 0.93 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
41,741.63
Trustee/s:
Mr. Pradeep Jagannath Bhi, LIC Mutual Fund Trustee P
Chairman:
NA
CEO / MD:
T.S. Ramakrishnan, Ravi Kumar Jha
CIO:
NA
President:
NA
Director/s:
Raghunandan Maluste, Vijay Sharma, Sanjay Achyutrao Muthal, Praveen Garg
Compliance Officer/s:
NA
Investor Service Officer/s:
Mr.Prashant Thakkar
Fund Manager/s:
Karan Doshi
Auditors:
S.R. Batliboi LLP
OTHER INFORMATION
Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Email:
Website:
